Joseph O Blanco - 19 Dec 2023 Form 4 Insider Report for CRAWFORD & CO (CRD-A)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Dec 2023, 09:03:46 UTC
Prior SEC filing
08 Dec 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joseph O. Blanco

Key filing fact

Joseph O Blanco filed Form 4 for CRAWFORD & CO (CRD-A) on 20 Dec 2023.

Key facts

  • This page summarizes Joseph O Blanco's Form 4 filing for CRAWFORD & CO (CRD-A).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 20 Dec 2023, 09:03.

Change

  • Previous filing in this sequence was filed on 08 Dec 2023.
  • Current net transaction value: -$168,256.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRDA CRDB transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+50,550
Change %
+21%
Price
$0.000000
Shares after
292,488
Date
19 Dec 2023
Ownership
Direct
CRDA CRDB transaction

Class A Common Stock

Tax liability

Transaction value
$168,256
Shares
-15,213
Change %
-5.2%
Price
$11.06
Shares after
277,275
Date
19 Dec 2023
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Joseph O Blanco is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .